ÂÜÀòÂÒÂ×

Sophie Lelievre is an accomplished researcher with extensive experience in cancer pharmacology and molecular biology. Currently holds positions as an associated researcher at Irset and a senior scientist at the Institut de Cancérologie de l'Ouest, where leadership is provided for the REGEN program and the SCaT laboratory. Concurrently, Sophie serves as a Professor Emerita of Cancer Pharmacology at Purdue University, having led significant research on chromatin and nucleoskeleton interactions in cancer. Prior roles include directing the 3D Cell Culture Core facility and contributing to drug delivery and molecular sensing programs at Purdue University Center for Cancer Research. Sophie's academic qualifications include an LLM in Health Law and Ethics, an MS and PhD in Molecular and Cellular Pharmacology, a DVM in Veterinary Medicine, and an engineering degree in veterinary science.